APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anxiety Disorders And Depression Therapeutic Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anxiety Disorders And Depression Therapeutic Drug Industry Growth and Trends Forecast to 2032

19 December 2025114 pages

Choose your research edition.

Industry ResearchAnxiety Disorders And Depression Therapeutic Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Anxiety Disorders And Depression Therapeutic Drug Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Anxiety Disorders And Depression Therapeutic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anxiety Disorders And Depression Therapeutic Drug Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Anxiety Disorders And Depression Therapeutic Drug Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

According to APO Research, the global Anxiety Disorders And Depression Therapeutic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anxiety Disorders And Depression Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anxiety Disorders And Depression Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anxiety Disorders And Depression Therapeutic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Anxiety Disorders And Depression Therapeutic Drug market include Takeda, Sanofi, Johnson & Johnson, Eli Lilly, Pfizer, GSK, AstraZeneca, Zhejiang Huahai and Shionogi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anxiety Disorders And Depression Therapeutic Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anxiety Disorders And Depression Therapeutic Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anxiety Disorders And Depression Therapeutic Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anxiety Disorders And Depression Therapeutic Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Anxiety Disorders And Depression Therapeutic Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anxiety Disorders And Depression Therapeutic Drug Market by Company

Takeda

Sanofi

Johnson & Johnson

Eli Lilly

Pfizer

GSK

AstraZeneca

Zhejiang Huahai

Shionogi

Otsuka Pharmaceutical

Merck & Co. Inc

Lundbeck

Kanghong Pharma

Bristol-Myers Squibb Company

APOTEX

Allergan

Anxiety Disorders And Depression Therapeutic Drug Segment by Type

Anticonvulsants

Atypical Antipsychotics

Benzodiazepines

Beta-Blockers

TeCAs

TCAs

SSRIs

SNRIs

MAOIs

Others

Anxiety Disorders And Depression Therapeutic Drug Segment by Application

Phobia

Obsessive-Compulsive Disorder (OCD)

Major Depressive Disorder (MDD)

Others

Anxiety Disorders And Depression Therapeutic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anxiety Disorders And Depression Therapeutic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anxiety Disorders And Depression Therapeutic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anxiety Disorders And Depression Therapeutic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Anxiety Disorders And Depression Therapeutic Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Anxiety Disorders And Depression Therapeutic Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Anxiety Disorders And Depression Therapeutic Drug Market Share by Region (2021-2026) Table 4. Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Anxiety Disorders And Depression Therapeutic Drug Market Share by Region (2027-2032) Table 6. Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Type (2021-2026) Table 9. Global Anxiety Disorders And Depression Therapeutic Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Anxiety Disorders And Depression Therapeutic Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Application (2021-2026) Table 24. Global Anxiety Disorders And Depression Therapeutic Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Anxiety Disorders And Depression Therapeutic Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Anxiety Disorders And Depression Therapeutic Drug Industry Trends Table 37. Anxiety Disorders And Depression Therapeutic Drug Industry Drivers Table 38. Anxiety Disorders And Depression Therapeutic Drug Industry Opportunities and Challenges Table 39. Anxiety Disorders And Depression Therapeutic Drug Industry Restraints Table 40. Global Anxiety Disorders And Depression Therapeutic Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Anxiety Disorders And Depression Therapeutic Drug Revenue Market Share by Company (2021-2026) Table 42. Global Anxiety Disorders And Depression Therapeutic Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Anxiety Disorders And Depression Therapeutic Drug Key Company Headquarters & Area Served Table 44. Global Anxiety Disorders And Depression Therapeutic Drug Company, Product Type & Application Table 45. Global Anxiety Disorders And Depression Therapeutic Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Anxiety Disorders And Depression Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 52. Takeda Recent Development Table 53. Sanofi Company Information Table 54. Sanofi Business Overview Table 55. Sanofi Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Sanofi Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 57. Sanofi Recent Development Table 58. Johnson & Johnson Company Information Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Johnson & Johnson Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 62. Johnson & Johnson Recent Development Table 63. Eli Lilly Company Information Table 64. Eli Lilly Business Overview Table 65. Eli Lilly Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Eli Lilly Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 67. Eli Lilly Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Pfizer Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 72. Pfizer Recent Development Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. GSK Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 77. GSK Recent Development Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. AstraZeneca Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 82. AstraZeneca Recent Development Table 83. Zhejiang Huahai Company Information Table 84. Zhejiang Huahai Business Overview Table 85. Zhejiang Huahai Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Zhejiang Huahai Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 87. Zhejiang Huahai Recent Development Table 88. Shionogi Company Information Table 89. Shionogi Business Overview Table 90. Shionogi Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Shionogi Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 92. Shionogi Recent Development Table 93. Otsuka Pharmaceutical Company Information Table 94. Otsuka Pharmaceutical Business Overview Table 95. Otsuka Pharmaceutical Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Otsuka Pharmaceutical Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 97. Otsuka Pharmaceutical Recent Development Table 98. Merck & Co. Inc Company Information Table 99. Merck & Co. Inc Business Overview Table 100. Merck & Co. Inc Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Merck & Co. Inc Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 102. Merck & Co. Inc Recent Development Table 103. Lundbeck Company Information Table 104. Lundbeck Business Overview Table 105. Lundbeck Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Lundbeck Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 107. Lundbeck Recent Development Table 108. Kanghong Pharma Company Information Table 109. Kanghong Pharma Business Overview Table 110. Kanghong Pharma Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Kanghong Pharma Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 112. Kanghong Pharma Recent Development Table 113. Bristol-Myers Squibb Company Company Information Table 114. Bristol-Myers Squibb Company Business Overview Table 115. Bristol-Myers Squibb Company Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Bristol-Myers Squibb Company Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 117. Bristol-Myers Squibb Company Recent Development Table 118. APOTEX Company Information Table 119. APOTEX Business Overview Table 120. APOTEX Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. APOTEX Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 122. APOTEX Recent Development Table 123. Allergan Company Information Table 124. Allergan Business Overview Table 125. Allergan Anxiety Disorders And Depression Therapeutic Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Allergan Anxiety Disorders And Depression Therapeutic Drug Product Portfolio Table 127. Allergan Recent Development Table 128. North America Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Anxiety Disorders And Depression Therapeutic Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Anxiety Disorders And Depression Therapeutic Drug Market Share by Country (2021-2026) Table 131. North America Anxiety Disorders And Depression Therapeutic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Anxiety Disorders And Depression Therapeutic Drug Market Share Forecast by Country (2027-2032) Table 133. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Anxiety Disorders And Depression Therapeutic Drug Market Share by Country (2021-2026) Table 136. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Anxiety Disorders And Depression Therapeutic Drug Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Share by Country (2021-2026) Table 141. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Share Forecast by Country (2027-2032) Table 143. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Share by Country (2021-2026) Table 146. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Share by Country (2021-2026) Table 151. Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Anxiety Disorders And Depression Therapeutic Drug Product Image Figure 3. Global Anxiety Disorders And Depression Therapeutic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Anxiety Disorders And Depression Therapeutic Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Anxiety Disorders And Depression Therapeutic Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Anxiety Disorders And Depression Therapeutic Drug Market Share by Region (2021-2032) Figure 7. North America Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Anticonvulsants Image Figure 13. Global Anticonvulsants Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Atypical Antipsychotics Image Figure 15. Global Atypical Antipsychotics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Benzodiazepines Image Figure 17. Global Benzodiazepines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Beta-Blockers Image Figure 19. Global Beta-Blockers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. TeCAs Image Figure 21. Global TeCAs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. TCAs Image Figure 23. Global TCAs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. SSRIs Image Figure 25. Global SSRIs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. SNRIs Image Figure 27. Global SNRIs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. MAOIs Image Figure 29. Global MAOIs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Others Image Figure 31. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Global Anxiety Disorders And Depression Therapeutic Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 33. Global Anxiety Disorders And Depression Therapeutic Drug Market Share by Type 2025 VS 2032 Figure 34. North America Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Type (2021-2032) Figure 35. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Type (2021-2032) Figure 36. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Type (2021-2032) Figure 37. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Type (2021-2032) Figure 38. Middle East and Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Type (2021-2032) Figure 39. Phobia Image Figure 40. Global Phobia Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Obsessive-Compulsive Disorder (OCD) Image Figure 42. Global Obsessive-Compulsive Disorder (OCD) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Major Depressive Disorder (MDD) Image Figure 44. Global Major Depressive Disorder (MDD) Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. Others Image Figure 46. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Global Anxiety Disorders And Depression Therapeutic Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 48. Global Anxiety Disorders And Depression Therapeutic Drug Market Share by Application 2025 VS 2032 Figure 49. North America Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Application (2021-2032) Figure 50. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Application (2021-2032) Figure 51. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Application (2021-2032) Figure 52. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Application (2021-2032) Figure 53. Middle East and Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Share by Application (2021-2032) Figure 54. Global Top 5 and 10 Anxiety Disorders And Depression Therapeutic Drug Players Market Share by Revenue in 2025 Figure 55. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 56. North America Anxiety Disorders And Depression Therapeutic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. North America Anxiety Disorders And Depression Therapeutic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. North America Anxiety Disorders And Depression Therapeutic Drug Market Share by Country (2021-2032) Figure 59. Europe Anxiety Disorders And Depression Therapeutic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Anxiety Disorders And Depression Therapeutic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Anxiety Disorders And Depression Therapeutic Drug Market Share by Country (2021-2032) Figure 62. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Share by Country (2021-2032) Figure 65. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Anxiety Disorders And Depression Therapeutic Drug Market Share by Country (2021-2032) Figure 68. Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 69. Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 70. Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Share by Country (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Anticonvulsants
  • Atypical Antipsychotics
  • Benzodiazepines
  • Beta-Blockers
  • TeCAs
  • TCAs
  • SSRIs
  • SNRIs
  • MAOIs
  • Others
Applications
  • Phobia
  • Obsessive-Compulsive Disorder (OCD)
  • Major Depressive Disorder (MDD)
  • Others
Companies covered
  • Takeda
  • Sanofi
  • Johnson & Johnson
  • Eli Lilly
  • Pfizer
  • GSK
  • AstraZeneca
  • Zhejiang Huahai
  • Shionogi
  • Otsuka Pharmaceutical
  • Merck & Co. Inc
  • Lundbeck
  • Kanghong Pharma
  • Bristol-Myers Squibb Company
  • APOTEX
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Anxiety Disorders And Depression Therapeutic Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Anxiety Disorders And Depression Therapeutic Drug Market Size (2021-2032)
  8. 1.5.1 North America Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (2021-2032)
2 Anxiety Disorders And Depression Therapeutic Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Anticonvulsants
  3. 2.1.2 Atypical Antipsychotics
  4. 2.1.3 Benzodiazepines
  5. 2.1.4 Beta-Blockers
  6. 2.1.5 TeCAs
  7. 2.1.6 TCAs
  8. 2.1.7 SSRIs
  9. 2.1.8 SNRIs
  10. 2.1.9 MAOIs
  11. 2.1.10 Others
  12. 2.2 Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Type
  13. 2.2.1 Global Anxiety Disorders And Depression Therapeutic Drug Market Size Overview by Type (2021-2032)
  14. 2.2.2 Global Anxiety Disorders And Depression Therapeutic Drug Historic Market Size Review by Type (2021-2026)
  15. 2.2.3 Global Anxiety Disorders And Depression Therapeutic Drug Market Size Forecasted by Type (2027-2032)
  16. 2.3 Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Regions
  17. 2.3.1 North America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2021-2026)
  18. 2.3.2 Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2021-2026)
  19. 2.3.3 Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2021-2026)
  20. 2.3.4 South America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2021-2026)
  21. 2.3.5 Middle East and Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Type (2021-2026)
3 Anxiety Disorders And Depression Therapeutic Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Phobia
  3. 3.1.2 Obsessive-Compulsive Disorder (OCD)
  4. 3.1.3 Major Depressive Disorder (MDD)
  5. 3.1.4 Others
  6. 3.2 Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Application
  7. 3.2.1 Global Anxiety Disorders And Depression Therapeutic Drug Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Anxiety Disorders And Depression Therapeutic Drug Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Anxiety Disorders And Depression Therapeutic Drug Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Anxiety Disorders And Depression Therapeutic Drug Market Size by Regions
  11. 3.3.1 North America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Anxiety Disorders And Depression Therapeutic Drug Industry Trends
  2. 4.2 Anxiety Disorders And Depression Therapeutic Drug Industry Drivers
  3. 4.3 Anxiety Disorders And Depression Therapeutic Drug Industry Opportunities and Challenges
  4. 4.4 Anxiety Disorders And Depression Therapeutic Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Anxiety Disorders And Depression Therapeutic Drug Revenue (2021-2026)
  2. 5.2 Global Anxiety Disorders And Depression Therapeutic Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Anxiety Disorders And Depression Therapeutic Drug Key Company Headquarters & Area Served
  4. 5.4 Global Anxiety Disorders And Depression Therapeutic Drug Company, Product Type & Application
  5. 5.5 Global Anxiety Disorders And Depression Therapeutic Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Anxiety Disorders And Depression Therapeutic Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Anxiety Disorders And Depression Therapeutic Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Anxiety Disorders And Depression Therapeutic Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 Eli Lilly
  20. 6.4.1 Eli Lilly Company Information
  21. 6.4.2 Eli Lilly Business Overview
  22. 6.4.3 Eli Lilly Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Eli Lilly Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  24. 6.4.5 Eli Lilly Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 GSK
  32. 6.6.1 GSK Company Information
  33. 6.6.2 GSK Business Overview
  34. 6.6.3 GSK Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 GSK Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  36. 6.6.5 GSK Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Zhejiang Huahai
  44. 6.8.1 Zhejiang Huahai Company Information
  45. 6.8.2 Zhejiang Huahai Business Overview
  46. 6.8.3 Zhejiang Huahai Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Zhejiang Huahai Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  48. 6.8.5 Zhejiang Huahai Recent Developments
  49. 6.9 Shionogi
  50. 6.9.1 Shionogi Company Information
  51. 6.9.2 Shionogi Business Overview
  52. 6.9.3 Shionogi Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Shionogi Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  54. 6.9.5 Shionogi Recent Developments
  55. 6.10 Otsuka Pharmaceutical
  56. 6.10.1 Otsuka Pharmaceutical Company Information
  57. 6.10.2 Otsuka Pharmaceutical Business Overview
  58. 6.10.3 Otsuka Pharmaceutical Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Otsuka Pharmaceutical Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  60. 6.10.5 Otsuka Pharmaceutical Recent Developments
  61. 6.11 Merck & Co. Inc
  62. 6.11.1 Merck & Co. Inc Company Information
  63. 6.11.2 Merck & Co. Inc Business Overview
  64. 6.11.3 Merck & Co. Inc Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Merck & Co. Inc Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  66. 6.11.5 Merck & Co. Inc Recent Developments
  67. 6.12 Lundbeck
  68. 6.12.1 Lundbeck Company Information
  69. 6.12.2 Lundbeck Business Overview
  70. 6.12.3 Lundbeck Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Lundbeck Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  72. 6.12.5 Lundbeck Recent Developments
  73. 6.13 Kanghong Pharma
  74. 6.13.1 Kanghong Pharma Company Information
  75. 6.13.2 Kanghong Pharma Business Overview
  76. 6.13.3 Kanghong Pharma Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Kanghong Pharma Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  78. 6.13.5 Kanghong Pharma Recent Developments
  79. 6.14 Bristol-Myers Squibb Company
  80. 6.14.1 Bristol-Myers Squibb Company Company Information
  81. 6.14.2 Bristol-Myers Squibb Company Business Overview
  82. 6.14.3 Bristol-Myers Squibb Company Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Bristol-Myers Squibb Company Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  84. 6.14.5 Bristol-Myers Squibb Company Recent Developments
  85. 6.15 APOTEX
  86. 6.15.1 APOTEX Company Information
  87. 6.15.2 APOTEX Business Overview
  88. 6.15.3 APOTEX Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 APOTEX Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  90. 6.15.5 APOTEX Recent Developments
  91. 6.16 Allergan
  92. 6.16.1 Allergan Company Information
  93. 6.16.2 Allergan Business Overview
  94. 6.16.3 Allergan Anxiety Disorders And Depression Therapeutic Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Allergan Anxiety Disorders And Depression Therapeutic Drug Product Portfolio
  96. 6.16.5 Allergan Recent Developments
7 North America
  1. 7.1 North America Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Anxiety Disorders And Depression Therapeutic Drug Market Size by Country (2021-2026)
  3. 7.3 North America Anxiety Disorders And Depression Therapeutic Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Anxiety Disorders And Depression Therapeutic Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Anxiety Disorders And Depression Therapeutic Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Anxiety Disorders And Depression Therapeutic Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Anxiety Disorders And Depression Therapeutic Drug Market Size by Country (2021-2026)
  3. 10.3 South America Anxiety Disorders And Depression Therapeutic Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Anxiety Disorders And Depression Therapeutic Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst